APA (7th ed.) Citation

De Wit, S., Bonnet, F., Osiyemi, O., Bisshop, F., Olalla, J., Routy, J., . . . Ait-Khaled, M. (2024). Durable Efficacy of Switching From a 3- or 4-Drug Tenofovir Alafenamide–Based Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine in the TANGO Study Through Week 196. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 96(2), 156. https://doi.org/10.1097/QAI.0000000000003395

Chicago Style (17th ed.) Citation

De Wit, Stéphane, et al. "Durable Efficacy of Switching From a 3- or 4-Drug Tenofovir Alafenamide–Based Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine in the TANGO Study Through Week 196." JAIDS: Journal of Acquired Immune Deficiency Syndromes 96, no. 2 (2024): 156. https://doi.org/10.1097/QAI.0000000000003395.

MLA (9th ed.) Citation

De Wit, Stéphane, et al. "Durable Efficacy of Switching From a 3- or 4-Drug Tenofovir Alafenamide–Based Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine in the TANGO Study Through Week 196." JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 96, no. 2, 2024, p. 156, https://doi.org/10.1097/QAI.0000000000003395.